Measles would likely be the first eradicated disease to return, because it is so highly contagious, but other diseases like rubella, diphtheria and polio could also return if vaccination rates fall by ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Health-care companies rose as earnings continued to come in strong. AbbVie shares rose after the drugmaker posted earnings ahead of Wall Street targets.

Shares of Novavax Inc. NVAX shed 5.66% to $6.67 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.26% to 17,382.94 ...

Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.

At some point within the first hour of waking up, expose yourself to natural light, preferably by taking a quick walk, Kaur ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...

Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to ...

EDT Novavax (NVAX) asked by FDA to complete additional COVID trial, WSJ saysStay Ahead of the Market: Discover outperforming stocks and ...